首页> 外文OA文献 >Immunoglobulin prevents complement-mediated hyperacute rejection in swine-to-primate xenotransplantation.
【2h】

Immunoglobulin prevents complement-mediated hyperacute rejection in swine-to-primate xenotransplantation.

机译:免疫球蛋白可防止猪至灵长类动物异种移植过程中补体介导的超急性排斥反应。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Immunoglobulins regulate the complement system by activating complement on foreign surfaces and diverting reactive complement proteins away from autologous cell surfaces. Based on this model, we explored the ability of Ig to balance complement activation versus control in a pig-to-primate cardiac xenotransplantation model in which the binding of xenoreactive antibodies of the recipient to graft blood vessels and the activation of complement cause hyperacute rejection. Human IgG added to human serum caused a dose-dependent decrease in deposition of iC3b, cytotoxicity, and heparan sulfate release when the serum was incubated with porcine endothelial cells. This decrease was not caused by alteration in antibody binding or consumption of complement but presumably reflected decreased formation of C3 convertase on the endothelial cells. Infusion of purified human IgG into nonhuman primates prevented hyperacute rejection of porcine hearts transplanted into the primates. As expected, the transplants contained deposits of recipient Ig and C1q but not other complement components. The inhibition of complement on endothelial cell surfaces and in the xenotransplantation model supports the idea that IgG regulates the classical complement pathway and supports therapeutic use of that agent in humoral-mediated disease.
机译:免疫球蛋白通过激活外源表面的补体并将反应性补体蛋白从自体细胞表面转移开来调节补体系统。基于此模型,我们探索了猪到灵长类动物异种移植模型中Ig平衡补体激活与对照的能力,在该模型中,受体的异种反应性抗体与移植血管的结合以及补体的激活引起超急性排斥。当将血清与猪内皮细胞一起孵育时,添加到人血清中的人IgG导致iC3b沉积,细胞毒性和硫酸乙酰肝素的释放呈剂量依赖性降低。这种减少不是由抗体结合的改变或补体的消耗引起的,而是可能反映了内皮细胞上C3转化酶形成的减少。将纯化的人IgG注入非人灵长类动物中可防止移植到灵长类动物中的猪心脏超急性排斥。正如预期的那样,这些移植物包含受体Ig和C1q的沉积物,但不包含其他补体成分。内皮细胞表面和异种移植模型中补体的抑制作用支持IgG调节经典补体途径并支持该剂在体液介导的疾病中的治疗用途。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号